Mehmet Hilmi Dogu

Mehmet Hilmi Dogu

Auto-generated profile, based on publicly available information

Mehmet Hilmi Dogu

Univ Hlth Sci Turkey, Istanbul Training & Res Hosp, Clin Hematol, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Hematological Oncology
Verified
Journal Article
Closed access
PDF file
OAOlga Meltem Akay
Olga Meltem Akay
MOMurat Ozbalak
Murat Ozbalak
MPMustafa Pehlivan
Mustafa Pehlivan
BYBirol Yildiz
Birol Yildiz
AUAnt Uzay
Ant Uzay
BFBurhan Ferhanoglu
Burhan Ferhanoglu

10 June 2021 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
SBSemih Başcı
Semih Başcı
NANaim Ata
Naim Ata
FAFevzi Altuntaş
Fevzi Altuntaş
TYTuğçe Nur Yiğenoğlu
Tuğçe Nur Yiğenoğlu
MDMehmet Sinan Dal
Mehmet Sinan Dal
ŞBŞuayip Birinci
Şuayip Birinci

13 November 2014 in Hematological Oncology
Verified
Journal Article
Closed access
PDF file
SHSibel Hacioglu
Sibel Hacioglu
YBYusuf Bilen
Yusuf Bilen
AEAli Eser
Ali Eser
SSSerdar Sivgin
Serdar Sivgin
EGEmel Gurkan
Emel Gurkan
AKAli Keskin
Ali Keskin

17 May 2012 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
PDF file
ISIsmail Sari
Ismail Sari
AAAliriza Arslan
Aliriza Arslan
COCan Ozlu
Can Ozlu
SHSibel Hacioglu
Sibel Hacioglu
MDMehmet Hilmi Dogu
Mehmet Hilmi Dogu
AKAli Keskin
Ali Keskin

1 February 2016 in Scottish Medical Journal
Verified
Journal Article
Open access
MDMehmet H Dogu
Mehmet H Dogu
ISIsmail Sari
Ismail Sari
SHSibel Hacioglu
Sibel Hacioglu
SDSerkan Degirmencioglu
Serkan Degirmencioglu
NŞNilay Şen
Nilay Şen
AKAli Keskin
Ali Keskin
Chronic lymphocytic leukaemia often has a clinical presentation characterised by increased neoplastic lymphocytes which are mostly mature looking due to B lymphocytes. Increased secondary cancer prevalence has been detected among patients with chronic lymphocytic leukaemia diagnosis. In this report, we present three chronic lymphocytic leukaemia patients who developed secondary rare cancers during their follow-up at our clinic. Case 1: A 54-year-old female patient was diagnosed with stage I chronic lymphocytic leukaemia in 2003 and was diagnosed with Merkel cell carcinoma in February 2013. Case 2: A 66-year-old male patient was diagnosed with stage II chronic lymphocytic leukaemia in 2009 and was diagnosed with Kaposi’s sarcoma in March 2013. Case 3: A 77-year-old male patient was diagnosed with stage I chronic lymphocytic leukaemia in 2006 and was diagnosed with Kaposi’s sarcoma in 2011. In conclusion, secondary cancers are observed in patients diagnosed with chronic lymphocytic leukaemia. Therefore, follow-up of chronic lymphocytic leukaemia requires additional attention in this context.

1 October 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
ISIstemi Serin
Istemi Serin
MDMehmet Hilmi Dogu
Mehmet Hilmi Dogu